Narayana Hrudayalaya Crecimiento futuro

Future controles de criterios 3/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Narayana Hrudayalaya de 8.5% y 11.6% por año respectivamente. Se prevé que el BPA crezca en un 8.6% al año. Se espera que la rentabilidad financiera sea de 21.4% en 3 años.

Información clave

8.5%

Tasa de crecimiento de los beneficios

8.6%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Healthcare	26.7%
Tasa de crecimiento de los ingresos	11.6%
Rentabilidad financiera futura	21.4%
Cobertura de analistas	Good
Última actualización	23 Apr 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

Narayana Hrudayalaya (NSE:NH) Is Very Good At Capital Allocation

Apr 09

Investor Optimism Abounds Narayana Hrudayalaya Limited (NSE:NH) But Growth Is Lacking

Mar 20

If EPS Growth Is Important To You, Narayana Hrudayalaya (NSE:NH) Presents An Opportunity

Mar 04

Investor Optimism Abounds Narayana Hrudayalaya Limited (NSE:NH) But Growth Is Lacking

Dec 20

Does Narayana Hrudayalaya (NSE:NH) Have A Healthy Balance Sheet?

Dec 05

We Think Narayana Hrudayalaya (NSE:NH) Might Have The DNA Of A Multi-Bagger

Nov 08

Here's Why We Think Narayana Hrudayalaya (NSE:NH) Might Deserve Your Attention Today

Oct 21

Narayana Hrudayalaya (NSE:NH) Could Easily Take On More Debt

Aug 01

Here's Why We Think Narayana Hrudayalaya (NSE:NH) Might Deserve Your Attention Today

Jul 07

The Trend Of High Returns At Narayana Hrudayalaya (NSE:NH) Has Us Very Interested

Jun 22

With EPS Growth And More, Narayana Hrudayalaya (NSE:NH) Makes An Interesting Case

Jan 19

We Think Shareholders Will Probably Be Generous With Narayana Hrudayalaya Limited's (NSE:NH) CEO Compensation

Aug 20

Narayana Hrudayalaya's (NSE:NH) Returns On Capital Are Heading Higher

Aug 07

Is Narayana Hrudayalaya (NSE:NH) Using Too Much Debt?

Dec 10

Previsiones de crecimiento de beneficios e ingresos

NSEI:NH - Estimaciones futuras de los analistas y datos financieros pasados (INR Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
3/31/2027	69,367	10,747	N/A	N/A	1
3/31/2026	65,385	9,451	5,803	N/A	8
3/31/2025	57,955	8,368	2,969	N/A	7
3/31/2024	50,991	8,089	117	N/A	8
12/31/2023	49,688	7,717	N/A	N/A	N/A
9/30/2023	48,933	7,375	5,102	10,323	N/A
6/30/2023	47,297	6,796	N/A	N/A	N/A
3/31/2023	45,297	6,062	5,625	10,846	N/A
12/31/2022	42,439	5,020	N/A	N/A	N/A
9/30/2022	40,755	4,457	5,587	8,093	N/A
6/30/2022	38,746	3,763	N/A	N/A	N/A
3/31/2022	37,013	3,419	2,343	4,850	N/A
12/31/2021	36,047	3,410	N/A	N/A	N/A
9/30/2021	33,954	2,843	4,082	4,783	N/A
6/30/2021	30,559	1,816	N/A	N/A	N/A
3/31/2021	25,839	-143	2,342	3,043	N/A
12/31/2020	25,049	-704	N/A	N/A	N/A
9/30/2020	25,397	-798	1,988	3,147	N/A
6/30/2020	27,677	-310	N/A	N/A	N/A
3/31/2020	31,365	1,189	3,275	4,433	N/A
12/31/2019	31,705	1,441	N/A	N/A	N/A
9/30/2019	31,152	1,254	2,191	3,691	N/A
6/30/2019	30,009	936	N/A	N/A	N/A
3/31/2019	28,740	592	1,286	2,786	N/A
12/31/2018	27,507	318	N/A	N/A	N/A
9/30/2018	25,728	332	N/A	N/A	N/A
6/30/2018	24,233	362	N/A	N/A	N/A
3/31/2018	22,943	513	-215	1,823	N/A
12/31/2017	21,243	639	N/A	N/A	N/A
9/30/2017	20,259	668	N/A	N/A	N/A
6/30/2017	19,494	767	N/A	N/A	N/A
3/31/2017	18,884	831	N/A	2,194	N/A
12/31/2016	18,220	637	N/A	N/A	N/A
9/30/2016	17,553	525	N/A	N/A	N/A
6/30/2016	16,868	364	N/A	N/A	N/A
3/31/2016	16,176	212	N/A	1,741	N/A
12/31/2015	15,471	219	N/A	N/A	N/A
3/31/2015	13,683	-168	N/A	767	N/A
3/31/2014	10,983	317	N/A	1,100	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (8.5% al año) de NH es superior a la tasa de ahorro (6.7%).

Beneficios vs. Mercado: Se prevé que los beneficios (8.5% al año) de NH crezcan menos que el mercado Indian (18% al año).

Beneficios de alto crecimiento: Se prevé que los beneficios de NH crezcan, pero no significativamente.

Ingresos vs. Mercado: Se prevé que los ingresos (11.6% al año) de NH crezcan más rápidamente que los del mercado Indian (10.3% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 11.6% al año) de NH crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de NH sea alta dentro de 3 años (21.4%)

Descubre empresas en crecimiento

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Narayana Hrudayalaya Crecimiento futuro

Future controles de criterios 3/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Price target increased by 8.1% to ₹1,390

Consensus EPS estimates increase by 16%

Price target increased by 8.2% to ₹1,070

Consensus EPS estimates increase by 11%

Price target increased by 7.5% to ₹943

Price target increased by 7.4% to ₹878

Recent updates

Narayana Hrudayalaya (NSE:NH) Is Very Good At Capital Allocation

Investor Optimism Abounds Narayana Hrudayalaya Limited (NSE:NH) But Growth Is Lacking

If EPS Growth Is Important To You, Narayana Hrudayalaya (NSE:NH) Presents An Opportunity

Price target increased by 8.1% to ₹1,390

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

Narayana Hrudayalaya Limited to Report Q3, 2024 Results on Feb 14, 2024

Investor Optimism Abounds Narayana Hrudayalaya Limited (NSE:NH) But Growth Is Lacking

Does Narayana Hrudayalaya (NSE:NH) Have A Healthy Balance Sheet?

Investor sentiment improves as stock rises 16%

Consensus EPS estimates increase by 16%

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

We Think Narayana Hrudayalaya (NSE:NH) Might Have The DNA Of A Multi-Bagger

Here's Why We Think Narayana Hrudayalaya (NSE:NH) Might Deserve Your Attention Today

Price target increased by 8.2% to ₹1,070

Consensus EPS estimates increase by 11%

Narayana Hrudayalaya Limited Approves Dividend for the Financial Year Ended March 31, 2023

Narayana Hrudayalaya Limited Announces Board Retirements, Effective August 7, 2023

Narayana Hrudayalaya (NSE:NH) Could Easily Take On More Debt

Narayana Hrudayalaya Limited to Report Q1, 2024 Results on Aug 02, 2023

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Narayana Hrudayalaya Limited Proposes Dividend for the Financial Year Ended March 31, 2023

Here's Why We Think Narayana Hrudayalaya (NSE:NH) Might Deserve Your Attention Today

Upcoming dividend of ₹2.50 per share at 0.3% yield

The Trend Of High Returns At Narayana Hrudayalaya (NSE:NH) Has Us Very Interested

Price target increased by 7.5% to ₹943

Full year 2023 earnings released: EPS: ₹29.85 (vs ₹16.85 in FY 2022)

Narayana Hrudayalaya Limited, Annual General Meeting, Aug 04, 2023

Narayana Hrudayalaya Limited to Report Q4, 2023 Results on May 19, 2023

Price target increased by 7.4% to ₹878

Narayana Hrudayalaya Limited Announces Board Appointments

Narayana Hrudayalaya Limited to Report Q3, 2023 Results on Feb 08, 2023

Narayana Hrudayalaya Limited Files Application for Strike-Off of Name of Wholly Owned Subsidiary, Narayana Health Institutions Private Limited

With EPS Growth And More, Narayana Hrudayalaya (NSE:NH) Makes An Interesting Case

Insufficient new directors

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Narayana Hrudayalaya Limited to Report Q2, 2023 Results on Nov 09, 2022

Narayana Hrudayalaya Limited (NSEI:NH) acquired Orthopedic and Trauma Hospital in Bengaluru from Shiva And Shiva Orthopaedic Hospital Private Limited.

Narayana Hrudayalaya (NSE:NH) Seems To Use Debt Rather Sparingly

Narayana Hrudayalaya Limited (NSEI:NH) signed a Business Transfer Agreement to acquire Orthopedic and Trauma Hospital in Bengaluru from Shiva And Shiva Orthopaedic Hospital Private Limited for INR 2 billion.

Narayana Hrudayalaya Limited (NSEI:NH) signed a Business Transfer Agreement to acquire Orthopedic and Trauma Hospital in Bengaluru from Shiva And Shiva Orthopaedic Hospital Private Limited for INR 2 billion.

Narayana Hrudayalaya Limited Approves the Dividend for the Financial Year Ended 31 March 2022

Upcoming dividend of ₹1.00 per share

Here's Why We Think Narayana Hrudayalaya (NSE:NH) Is Well Worth Watching

Narayana Hrudayalaya Limited Proposes Dividend for the Financial Year Ended 31 March 2022

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

Narayana Hrudayalaya Limited to Report Q1, 2023 Results on Aug 08, 2022

Narayana Health Announces Appointment of Ashish Bajaj as the Chief Marketing Officer

We Think Narayana Hrudayalaya (NSE:NH) Might Have The DNA Of A Multi-Bagger

Full year 2022 earnings: EPS misses analyst expectations

Narayana Hrudayalaya Limited Recommends Dividend for the Year Ended March 31, 2022

Price target increased to ₹729

Insufficient new directors

Insufficient new directors

Narayana Hrudayalaya Limited Announces Appointment of Viren Prasad Shetty as Executive Vice-Chairman

Returns On Capital Are A Standout For Narayana Hrudayalaya (NSE:NH)

Insufficient new directors

Price target increased to ₹707

Third quarter 2022 earnings: EPS and revenues exceed analyst expectations

Is Narayana Hrudayalaya (NSE:NH) A Risky Investment?

A Look At The Intrinsic Value Of Narayana Hrudayalaya Limited (NSE:NH)

Second quarter 2022 earnings released: EPS ₹4.89 (vs ₹0.17 loss in 2Q 2021)

We Think Narayana Hrudayalaya (NSE:NH) Can Manage Its Debt With Ease

We Think Shareholders Will Probably Be Generous With Narayana Hrudayalaya Limited's (NSE:NH) CEO Compensation

Narayana Hrudayalaya's (NSE:NH) Returns On Capital Are Heading Higher

First quarter 2022 earnings released: EPS ₹3.75 (vs ₹5.90 loss in 1Q 2021)

Additional Non-Executive & Independent Director Nivruti Rai has left the company

Full year 2021 earnings released: ₹0.70 loss per share (vs ₹5.86 profit in FY 2020)

Price target increased to ₹525

Narayana Hrudayalaya Limited to Report Q3, 2021 Results on Feb 05, 2021